Page last updated: 2024-11-02

palmidrol and Compensatory Hyperinsulinemia

palmidrol has been researched along with Compensatory Hyperinsulinemia in 1 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdulnour, J1
Yasari, S1
Rabasa-Lhoret, R1
Faraj, M1
Petrosino, S1
Piscitelli, F1
Prud' Homme, D1
Di Marzo, V1

Other Studies

1 other study available for palmidrol and Compensatory Hyperinsulinemia

ArticleYear
Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Obesity (Silver Spring, Md.), 2014, Volume: 22, Issue:1

    Topics: Amides; Arachidonic Acids; Body Composition; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Co

2014